Thalassemia

Patients Benefit From Haemophilus influenzae Vaccine

Published in Vaccine Weekly, June 13th, 2001

by N.R. Saltmarsh, staff medical writer - People with thalassemia, especially those who have undergone splenectomy, can benefit from vaccination against Haemophilus influenzae type b (Hib), but an effective booster regimen still needs to be established, according to a new report in the Journal of Infectious Diseases.

Though clinicians were aware that these patients were more susceptible to infectious diseases and need vaccinations and antimicrobial prophylaxis, no vaccine protocol for Hib had been established, said R. Cimaz and colleagues in Italy.

They measured Hib antibodies in 57 thalassemia patients, 32 of whom had undergone...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-06-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry